Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to ... [+] criticism over problems that led to the shutdown of one of its infant formula-producing plants. (Stacey Wescott/Chicago Tribune/Tribune News Service via Getty Images) TNS Abbott (NYSE: ABT) reported its Q4 results last month, with revenues above and earnings aligning with the street estimates. The company reported revenue of $10.24 billion and earnings of$1.19 on a per-share and adjusted basis, comp ...